Vice President, Clinical Affairs
Tricia has over 22 years of experience working in an FDA regulated environment. At Angel Medical Systems, she began supporting Quality and Regulatory Systems in 2008 and took over the responsibility for data management of the ALERTS Clinical Trial in 2011. She was a key contributor to the Pre-Market Approval submission, including the Amendment that led to FDA approval of the Angel Medical Systems Guardian®. Tricia is now the head of all clinical operations for Angel Medical Systems.
Before joining Angel Medical Systems, Tricia capitalized on her previous work experiences and acted as an Independent Consultant to several Pharmaceutical and Medical Device Industries, including Johnson & Johnson, where she was responsible for quality control audits of regulatory submissions for investigational new drugs and devices. Tricia began her career at Exxon Biomedical Sciences, followed by J&J Pharmaceutical Research and Development in the Reproductive Toxicology labs where she ran pre-clinical studies and coordinated the validation and implementation of a neurobehavioral toxicology test program. Tricia studied at Purdue University earning her Bachelor of Science in Biology. She has received certifications in Quality System Regulation and Clinical Monitoring for Medical Devices. She is co-author of abstracts and publications in Neurotoxicology and Teratology.